Vinorelbine alternating oral and intravenous plus epirubicin in first-line therapy of metastatic breast cancer: results of a multicentre phase II study

The combination of intravenous (i.v.) vinorelbine and epirubicin is highly active in the treatment of metastatic breast cancer (MBC). In an effort to improve patient convenience, we investigated a regimen alternating i.v. and oral vinorelbine in combination with epirubicin as first-line chemotherapy...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Serin, D, Verrill, M, Jones, A, Delozier, T, Coleman, R, Kreuser, E-D, Mross, K, Longerey, B, Brandely, M
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2005
Assuntos:
Clinical Study
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361780/
https://ncbi.nlm.nih.gov/pubmed/15928659
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602588
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares